Keyword: antibody

Research / Laboratory

Improving ADC Production and Purification

Lonza AG -

How Optimizing Process Parameters Can Improve Scalability and Manufacturability of a Cytotoxic Antibody Drug Conjugate.


CMC Biologics Hikes Capacity in Denmark

29.09.2017 - CMC Biologics, a wholly owned subsidiary of Japan’s Asahi Glass Company (AGC), will raise capacity at its site in Copenhagen, Denmark, to meet increasing demand for antibody drug...


Shire Takes Novimmune’s Blood Therapy Rights

26.07.2017 - Shire has obtained exclusive worldwide rights from Novimmune for a bi-specific antibody that is currently in pre-clinical development for treating patients with the blood disorders...


Merck Takes Antibody License from Teijin

31.05.2017 - US drugmaker Merck has bought an exclusive global licence from Japan’s Teijin Pharma to develop, manufacture and commercialize an investigational preclinical antibody candidate...


MRC Licenses Hepatitis C Antibody to China

21.03.2017 - UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading Chinese drug developer, in an effort to create a novel therapeutic for...


Mundipharma to Launch Biosimilar Truxima in Europe

28.02.2017 - UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...


Merck Settles Keytruda Patent Disputes

24.01.2017 - US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...


MedImmune and Abpro Spin Out Antibody Firm

02.12.2016 - AstraZeneca’s biologics R&D arm MedImmune and US life sciences group Abpro have spun out a new company – AbMed – to advance the development of a preclinical, novel bispecific...